Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jennifer Cooperrider"'
Autor:
Benjamin A. Derman, Ajay Major, Jennifer Cooperrider, Ken Jiang, Aubrianna Ramsland, Theodore Karrison, Tadeusz Kubicki, Andrzej J. Jakubowiak
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract MRD2STOP is a pragmatic trial evaluating maintenance therapy cessation guided by measurable residual disease (MRD) negativity in multiple myeloma (MM). Eligible patients had previous MRD
Externí odkaz:
https://doaj.org/article/03712b7429334a0db4dd04bdc036fead
Autor:
Benjamin A. Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, David E. Avigan, Murtuza Rampurwala, David Barnidge, Ajay Major, Theodore Karrison, Ken Jiang, Aubrianna Ramsland, Tadeusz Kubicki, Andrzej J. Jakubowiak
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract We evaluated the efficacy and safety of 24 cycles of Dara in combination with carfilzomib (K), lenalidomide (R), and dexamethasone (d) without autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM) irrespective of
Externí odkaz:
https://doaj.org/article/83561b47ec1741d597e7e790e6a0d5db
Autor:
Deborah M. Stephens, Ken Boucher, Elizabeth Kander, Sameer A. Parikh, Erin M. Parry, Mazyar Shadman, John M. Pagel, Jennifer Cooperrider, Joanna Rhodes, Anthony Mato, Allison Winter, Brian Hill, Sameh Gaballa, Alexey Danilov, Tycel Phillips, Danielle M. Brander, Sonali M. Smith, Matthew Davids, Kerry Rogers, Martha J. Glenn, John C. Byrd
Publikováno v:
Haematologica, Vol 106, Iss 11 (2020)
Chronic lymphocytic leukemia (CLL) patients who develop Hodgkin lymphoma (HL) have limited survival. No current therapeutic standard of care exists. We conducted a multi-center retrospective study of patients with Hodgkin transformation (HT) of CLL.
Externí odkaz:
https://doaj.org/article/0260f2bf0b3e47f7bd3285461f73f519
Autor:
Noreen Fulton, Jennifer Cooperrider, Hongtao Liu, Richard A. Larson, Satyajit Kosuri, Michael R. Bishop, Andrew S. Artz, Wendy Stock
Publikováno v:
Bone Marrow Transplantation. 55:2204-2206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::448e53986fcb8c1b96d779e983c1650f
https://doi.org/10.1038/s41409-020-0925-2
https://doi.org/10.1038/s41409-020-0925-2
Autor:
Kenneth M. Boucher, Jennifer Cooperrider, Anthony R. Mato, Deborah M. Stephens, Sameer A. Parikh, Matthew S. Davids, Alexey V. Danilov, Martha Glenn, Kerry A. Rogers, Elizabeth Kander, Sonali M. Smith, Joanna Rhodes, Allison M. Winter, Sameh Gaballa, Brian T. Hill, Mazyar Shadman, Erin M. Parry, John M. Pagel, Tycel Phillips, John C. Byrd, Danielle M. Brander
Publikováno v:
Haematologica
Chronic lymphocytic leukemia (CLL) patients who develop Hodgkin lymphoma (HL) have limited survival. No current therapeutic standard of care exists. We conducted a multi-center retrospective study of patients with Hodgkin transformation (HT) of CLL.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6ae24857bfd73885bd0a56ac99fd4d
https://pubmed.ncbi.nlm.nih.gov/33054118
https://pubmed.ncbi.nlm.nih.gov/33054118
Autor:
Mazyar Shadman, Allison M. Winter, Kerry A. Rogers, Kenneth M. Boucher, Matthew S. Davids, Jennifer Cooperrider, Brian T. Hill, Elizabeth Kander, Sameh Gaballa, Martha Glenn, Tycel Phillips, Sonali M. Smith, Danielle M. Brander, John M. Pagel, John C. Byrd, Erin M. Parry, Joanna Rhodes, Deborah M. Stephens, Anthony R. Mato, Alexey V. Danilov, Sameer A. Parikh
Publikováno v:
Blood. 132:1648-1648
Introduction Transformation of chronic lymphocytic leukemia (CLL) into Hodgkin lymphoma (HL) is a rare, but recognized complication of CLL. The prognosis of CLL with HL Transformation (HT) appears significantly worse than de novo HL, but most series
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50d294265756242df7a587eb0356d4a5
https://doi.org/10.1182/blood-2018-99-113173
https://doi.org/10.1182/blood-2018-99-113173